Healthcare Shares

As the first fund of its kind in the region, we specialize in early-stage investments, empowering bold entrepreneurs with the capital, mentorship, and resources to bring their visionary ideas to life. By partnering with groundbreaking tech founders at the outset of their journey, we’re shaping the future of innovation in one of the world’s most dynamic and rapidly evolving markets. Operating in Ever Growing - Venture Capital Industry - India & South East Asia Over the past decade, the venture capital industry in India and Southeast Asia has experienced remarkable growth, with significant capital being deployed as risk capital to fuel the region's innovation and startup ecosystem. In the last 10 years, more than $750 billion has been invested in emerging startups across sectors like technology, fintech, healthcare, and e-commerce. This surge in venture funding reflects the growing confidence of global investors in the potential of these markets, driven by a rapidly expanding digital economy, a large consumer base, and an increasingly vibrant entrepreneurial landscape. Landscape of Technology India's technology industry is expected to reach US$254 billion in revenue in 2024, with exports reaching US$200 billion. Adherence to Strong ESG Principles Collaborate with company that focus more on ESG implementation which provides edge to our portfolio to access advantage of impact funding & other benefits available specifically for ESG compliant companies. Target Companies Technologically Enabled Business Model Scalable Model Seed to Series A Profitable and Near to Profitability Cheque Size of up to $500K with follow-up round ESG & Impact Funding

Address the critical bottlenecks in both established and emerging markets that limit access and affordability to novel cancer solutions. Inculcate the tenets of ESG (Environmental, Social and Governance) based investing and measure the progress and impact of our portfolio using the following metrics: E: The ability to optimize differential drug and device pricing based on geography and expand access to promising products early in their lifecycle S: Ability to boost R&D productivity through operational optimization and process transformation G: Promote ethical conduct of business and collaboration while ensuring inclusion & diversity What We DoInvest in US and EU based cancer start-ups who are keen to explore emerging markets or engage in collaborative R&D. Streamline the product-market fit and ensure access to supportive infrastructure and resources. Facilitate their collaborative R&D/commercialization strategy in geographies of interest. How We Do It Accelerate the path to successful commercialization for US and EU based start-ups developing the next generation of oncology solutions by: Reducing costs through infrastructure consolidation and collaborative expertise Expanded access to capital Facilitating rapid market penetration and commercial scaling​

At StartUp Health, we are impact-driven entrepreneurs and investors building a global army of thousands of Health Transformers collaborating to achieve health moonshots --- from ending cancer and curing disease, like diabetes and Alzheimer’s, to delivering quality care to everyone in the world regardless of location or income. We believe that investing in and supporting a diversified global portfolio of health moonshot companies is the key to improving the health and wellbeing of humanity, while also generating healthy financial returns for investors. Since 2012, we’ve made more than 400 investments in companies across 27 countries, and currently have a portfolio of 260+ active companies. We have a flexible, work-from-anywhere policy as our team is fully remote, with team members in NYC, San Francisco, Los Angeles, Baltimore, and Philadelphia. We are open to candidates across the U.S. Benefits include health insurance and long-term disability coverage, 401k with employer matching, employee stock options, and generous time off policy including paid holidays.

What differentiates Wavemaker 360 the most is the fact that the majority of our investors come from the healthcare industry. We think of them as our company's lifeguards, providing all sorts of support and services to our portfolio companies. Wavemaker 360’s Limited Partners include healthcare corporates, family offices with healthcare backgrounds, and more than 100 individual investors that have spent their career in the healthcare industry. Collectively this group of investors is our secret weapon and superpower - they are willing and able to commercially support the companies we invest into. In fact, for many of them, getting more connectivity to healthcare innovation is a primary reason they are involved with Wavemaker 360. These Limited Partners combine to make Wavemaker 360 the most strategic healthcare-focused venture fund in the US and give the fund an “unfair advantage” when it comes to sourcing high quality investment opportunities, evaluating early-stage companies, and providing commercial support post-investment.

Bert-Arjan Millenaar, CEO and founder of NLC, went through this first-hand. His experience proves why NLC is an essential company that significantly impacts society every day. In May 2014, Bert-Arjan became the proud father of a little girl. Unfortunately, she was born prematurely, leaving him helpless next to her incubator. He desperately wanted nothing more than to hold his little girl and bring her home. At the time, Bert-Arjan didn’t know that a professor across the country was working on an invention that could have prevented his pain. A lack of entrepreneurship and network kept the professors’ innovation (Concord Neonatal) out of our healthcare system. Unfortunately, this is just one of many stories with the same plot: a patient is in critical need of equipment that has not yet been brought to the market. We at NLC have made it our mission to change this. We find inventions, select the most promising ones, and build them into viable healthtech ventures to advance health. Since 2015, NLC has evaluated thousands of inventions and built over 100 ventures. We have a great team of dedicated employees and industry experts (+3000 individuals) who enable us to continue our mission daily. We guarantee that you are in safe, trustworthy hands! Together we are building ventures and advancing health for patients worldwide. In addition, we are an experienced fund manager that makes healthcare innovation investible for retail and institutional investors. HOW DO WE ACHIEVE SUCCESS? THROUGH ENTREPRENEURSHIP AT SCALE! We strongly believe that the most successful way to bring more healthtech inventions to patients is by using entrepreneurship at scale. Entrepreneurship is essential to get a venture through the early stages, and this is where you need to put in the hard work on many levels simultaneously. The dedication of the CEOs and their team is crucial to getting the venture to the market successfully. By building ventures at scale, we can benefit from the data and learnings we’ve harvested along the way. We know the pitfalls. We know the shortcuts. We try hard, and if we fail, we fail fast. To support a venture, we build teams around it that know what it takes to make a venture successful. We surround our CEOs with expertise and support in all areas, from helping to secure finance, providing advice on patents and certifications, training the team on sales, and everything in between. OUR NETWORK Our network is essential to us and plays a crucial role in our journey to success. Committed specialists worldwide support our team through our venture-building process. We partner with 4 groups of people, and together we strive for success! Inventors and research institutes that want to bring their inventions to the market with us, Medical, technical and business specialists that help us evaluate the inventions, Investors that are willing to take the risk and invest in early seed start-ups, Entrepreneurs and advisors that help us grow the ventures we have built. Together, we overcome fragmentation so we can build ventures and advance health. HOW DO WE HELP YOU LOWER YOUR RISK CURVE? NLC operates at the beginning of the risk curve, where the risk is high, and the invested capital is relatively low. This opens the opportunity for us to make an impact by utilising our entrepreneurship at scale to lower the risk curve of our ventures. Our ventures are de-risked at a faster rate with low(er) costs, which scales NLC’s portfolio further (statistically) and de-risks our model. This means fewer risks and more rewards!

Northwell Holdings helps to advance medical technology and promote the development of Northwell Health enterprises by investing in novel ideas and business models across the health care landscape. What we do:We invest in early stage, innovative companies with strategic alignment to the health system’s goals. We develop and commercialize internal innovations invented by Northwell team members. We create and bring new products and medical devices to market through development of internal innovation and strategic partnerships. We advance the identification and realization of novel data assets. We align with partners across industry verticals to create joint ventures and strategic partnerships. Improving the future of health care Our mission is to improve the future of health care by investing in companies that drive quality health outcomes, increasing operating efficiency, lowering the overall costs of health care, and - most importantly - improving patient experience. We use the vast medical resources of Northwell Health to build new technologies and progress new ideas in both clinical and non-clinical areas. Our team has deep experience with entrepreneurial ventures, from starting and investing in early-stage companies to providing strategy and management consulting services to a portfolio of businesses. Our goal is to transform innovative health care concepts and solutions into profitable businesses for Northwell and beyond.